SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-21-045702
Filing Date
2021-04-01
Accepted
2021-04-01 17:21:33
Documents
4
Period of Report
2021-04-01

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tm2110673d5_6k.htm 6-K 19770
2 EXHIBIT 1.1 tm2110673d5_ex1-1.htm EX-1.1 221169
3 EXHIBIT 5.1 tm2110673d5_ex5-1.htm EX-5.1 40213
4 EXHIBIT 99.1 tm2110673d5_ex99-1.htm EX-99.1 9408
  Complete submission text file 0001104659-21-045702.txt   291591
Mailing Address ZERNIKEDREEF 9 LEIDEN P7 2333 CK
Business Address ZERNIKEDREEF 9 LEIDEN P7 2333 CK 31 88 166 7000
ProQR Therapeutics N.V. (Filer) CIK: 0001612940 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36622 | Film No.: 21799349
SIC: 2834 Pharmaceutical Preparations